The molecular signature of inflammation is detected by a wearable sweat sensor.

Published Date: 28 Jun 2023

From arthritis to Zika fever, the vast majority of human diseases and disorders involve some degree of inflammation. Despite the fact that we are most familiar with inflammation as pain, redness, and swelling, a variety of.

Read Full News

Latest News

Enhancing Clinical Efficiency with AI to Prioritize Patient Care, with Ellen Gelles, MD Ellen Gelles, MD

Gelles discussed AI tools that are becoming a part of clinician’s armamentariums and the impact they are having on the field.

Addressing Community Health Needs for Comprehensive Care, with Mindy Hoang, MD Mindy Hoang, MD

Hoang discussed the CARD initiative started at Wayne State University in Detroit that she presented at the ACP IM 2025 meeting.

FDA Commissioner Marty Makary Resigns, Kyle Diamantas Steps In as Acting Head

FDA Commissioner Marty Makary Resigns, Kyle Diamantas Steps In as Acting Head

Experts Weigh Best Practices for Deprescribing

Nearly 3 in 10 Italians older than 65 years take more than 10 medications, highlighting why deprescribing is gaining attention as a strategy to improve care.

Experts Debate Combination Therapy for Pulmonary Fibrosis

Respiratory experts disagree over initiating upfront dual therapy vs sequential escalation as next-generation antifibrotics emerge for pulmonary fibrosis.

Keto Diet Boosts Liver Health More Than Others in Obesity

A ketogenic diet paired with weight loss improves liver health more than a Mediterranean or very low-fat diet with similar weight loss in people with metabolically unhealthy obesity.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

Gelles discussed AI tools that are becoming a part of clinician’s armamentariums and the impact they are having on the field.

Hoang discussed the CARD initiative started at Wayne State University in Detroit that she presented at the ACP IM 2025 meeting.

FDA Commissioner Marty Makary Resigns, Kyle Diamantas Steps In as Acting Head

Nearly 3 in 10 Italians older than 65 years take more than 10 medications, highlighting why deprescribing is gaining attention as a strategy to improve care.

Respiratory experts disagree over initiating upfront dual therapy vs sequential escalation as next-generation antifibrotics emerge for pulmonary fibrosis.

A ketogenic diet paired with weight loss improves liver health more than a Mediterranean or very low-fat diet with similar weight loss in people with metabolically unhealthy obesity.

News All Time

Three-Step Triage May Speed Assessment of Rheumatic Diseases

A three-step triage system may help reduce wait times for patients with inflammatory rheumatic and musculoskeletal disease, although it may still miss some diagnoses.

Breaking the Lab Habit: Rethinking Daily Hospital Testing

Not every patient needs routine daily testing. Breaking the habit can save money and improve patient health. But some habits are hard to break.
HTTP error: 503HTTP error: 503

Can Sexual Experience Reshape the Brain?

New research is exploring whether sexual experience may shape brain circuits linked to reward, learning, and mood — but the human evidence remains early.

Somatic Mutations Shape Systemic Autoinflammatory Disease

Acquired somatic variants may drive over 20% of systemic autoinflammatory disease diagnoses, with VEXAS syndrome and cryopyrin-associated periodic syndromes representing the majority of cases.
HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

Long-Term Primary Care Saves Lives — and Is Hard to Achieve

New research quantifies the benefits of long-term patient relationships. How can you build them in a system that prioritizes high-volume access?

Size Matters for Chest Tubes

New data show similar outcomes with large-bore and small-bore chest tubes in patients with pneumothoraces.

UnitedHealthcare to Drop Prior Authorization Requirements for Range Of Conditions From Oct. 1

UnitedHealth's insurance unit said on Tuesday that a broad range of conditions will no ⁠longer need prior approval, effective October 1, as it aims to eliminate prior...

Rilzabrutinib May Be Promising in IgG4-Related Disease

Rilzabrutinib treatment is associated with a reduction in disease activity in patients with IgG4-related disease and enables most patients to discontinue glucocorticoids without experiencing flares.

What to Know About ‘Musculoskeletal Syndrome of Menopause’

Is new joint pain in perimenopause simple arthralgia or underlying inflammatory arthritis? Learn key diagnostic steps, seronegative RA risks, and hormone replacement therapy insights.

Recommended News For You

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

Race, Geography Linked to Gaps in Prostate Cancer Care

Novel probes to label macrophages associated with cancer progression using a selective dye

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Time to Rethink Maintenance Pemetrexed in NSCLC?

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

Recommended Articles For You

Exploring the Latest Advances in Hodgkin's Lymphoma Treatment 

Circulating Tumor DNA Dynamics for Therapy Matching: A Comprehensive Clinical Review 

Quality of Life Through Personalized Survivorship Navigation After Multimodal Cancer Therapy 

Screening for Early Changes in Blood-Cell Production Capacity in Older Adults 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TULSA Is Effective in Long-Term Prostate Cancer Control.

2.

AVD Chemo Regimen Shows Promise in Older Patients With HL

3.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

4.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

5.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

1.

Programmable Cell Therapies for Selective Removal of Dysfunctional Hematopoietic Cell Populations

2.

Contemporary Insights in Oncology in the Digital Era

3.

Strategic Concepts in Hematology for Modern Medicine

4.

Ferroptosis-Modulating Therapeutics in Precision Oncology

5.

Exploring the Potential of Bendamustine in Cancer Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

2.

Blood Clotting Disorders Explained

3.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

4.

Chemotherapy: What to Expect

5.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot